Literature DB >> 17372682

Amphotericin B-gum arabic conjugates: synthesis, toxicity, bioavailability, and activities against Leishmania and fungi.

K K Nishi1, M Antony, P V Mohanan, T V Anilkumar, P M Loiseau, A Jayakrishnan.   

Abstract

PURPOSE: Gum arabic, a branched polysaccharide consisting of more than 90% arabinogalactan having a molecular weight around 250,000 Da is the oldest and best known of all natural gums. The objective of the present investigation was to examine whether amphotericin B (AmB), the polyene antibiotic when conjugated to periodate oxidized gum arabic still retained its anti-fungal and anti-leishmanial activity and to evaluate its toxicity and bioavailability.
METHODS: AmB conjugated to the oxidized polysaccharide through Schiff's linkages in the unreduced (imine) and reduced (amine) forms were characterized for the drug content, hemolytic potential, molecular mass, in vitro release and were examined for anti-fungal activity against Candida albicans and Cryptococcus neoformans and for anti-leishmanial activity against promastigotes of Leishmania donovani in culture. Toxicity and bioavailability were evaluated by intravenous (i.v) injections of the conjugates in mice and rabbits respectively.
RESULTS: The conjugates were found to be non-hemolytic and mice withstood a dosage of 20 mg (AmB)/kg body weight of both conjugates. Histological examination of the internal organs of mice showed no lesions in kidney, brain, heart or liver. Estimation of the residual drug in the internal organs 7 days post injection showed that the spleen still retained 8.4 +/- 0.53 microg/g of tissue. AmB was found to be released from both conjugates in vitro although the release from the imine conjugate was much faster than from the amine conjugate. The concentrations inhibiting parasite growth by 50% (IC(50)) values for the imine conjugate against promastigotes of L. donovani LV9 and DD8 strains were 0.37 +/- 0.04 and 1.44 +/- 0.18 microM respectively. The IC(50) values for the amine conjugates were much higher. The minimum inhibitory concentration (MIC) against C. albicans and C. neoformans was in the range of 0.5-0.9 microg/mL for both imino and amino conjugates. The bioavailability of the conjugate in rabbits showed that the imine conjugate maintained a plasma concentration in the range of 20 to 5 microg/mL while for the amine conjugate it was in the range of 17 to 3 microg/mL over 24 h.
CONCLUSIONS: The drug conjugates were stable, non-hemolytic and non-toxic to the internal organs of the animal and showed good anti-fungal and anti-leishmanial activity in vitro. In spite of the large molecular weight of the polysaccharide, AmB from the conjugates showed bioavailability after i.v injection. Since the highest concentration of AmB was found in the spleen after a single injection, these conjugates may have potential in anti-leishmanial therapy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17372682     DOI: 10.1007/s11095-006-9222-z

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.580


  27 in total

Review 1.  Amphotericin B nephrotoxicity.

Authors:  Gilbert Deray
Journal:  J Antimicrob Chemother       Date:  2002-02       Impact factor: 5.790

2.  Activity of liposomal amphotericin B against experimental cutaneous leishmaniasis.

Authors:  V Yardley; S L Croft
Journal:  Antimicrob Agents Chemother       Date:  1997-04       Impact factor: 5.191

3.  A novel injectable water-soluble amphotericin B-arabinogalactan conjugate.

Authors:  R Falk; A J Domb; I Polacheck
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

Review 4.  Amphotericin B: 30 years of clinical experience.

Authors:  H A Gallis; R H Drew; W W Pickard
Journal:  Rev Infect Dis       Date:  1990 Mar-Apr

5.  Comparison of the efficacies of various formulations of amphotericin B against murine visceral leishmaniasis.

Authors:  A B Mullen; K C Carter; A J Baillie
Journal:  Antimicrob Agents Chemother       Date:  1997-10       Impact factor: 5.191

6.  Distribution of amphotericin B-arabinogalactan conjugate in mouse tissue and its therapeutic efficacy against murine aspergillosis.

Authors:  Rama Falk; Jacob Grunwald; Amnon Hoffman; Abraham J Domb; Itzhack Polacheck
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

7.  New lipid formulation of amphotericin B: spectral and microscopic analysis.

Authors:  Malika Larabi; Annette Gulik; Jean-Paul Dedieu; Philippe Legrand; Gillian Barratt; Monique Cheron
Journal:  Biochim Biophys Acta       Date:  2004-08-30

8.  In vitro antileishmanial activity of acetogenins from Annonaceae.

Authors:  S Raynaud-Le Grandic; C Fourneau; A Laurens; C Bories; R Hocquemiller; P M Loiseau
Journal:  Biomed Pharmacother       Date:  2004 Jul-Aug       Impact factor: 6.529

9.  Toxicity and antileishmanial activity of a new stable lipid suspension of amphotericin B.

Authors:  Malika Larabi; Vanessa Yardley; Philippe M Loiseau; Martine Appel; Philippe Legrand; Annette Gulik; Christian Bories; Simon L Croft; Gillian Barratt
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

10.  Effects of the aggregation state of amphotericin B on its toxicity to mice.

Authors:  J Barwicz; S Christian; I Gruda
Journal:  Antimicrob Agents Chemother       Date:  1992-10       Impact factor: 5.191

View more
  6 in total

1.  Toxicity mechanisms of amphotericin B and its neutralization by conjugation with arabinogalactan.

Authors:  Sarah Kagan; Diana Ickowicz; Miriam Shmuel; Yoram Altschuler; Edward Sionov; Miriam Pitusi; Aryeh Weiss; Shimon Farber; Abraham J Domb; Itzhack Polacheck
Journal:  Antimicrob Agents Chemother       Date:  2012-08-20       Impact factor: 5.191

2.  Injectable in situ cross-linking hydrogels for local antifungal therapy.

Authors:  Sarah P Hudson; Robert Langer; Gerald R Fink; Daniel S Kohane
Journal:  Biomaterials       Date:  2009-11-26       Impact factor: 12.479

3.  Oral administration of amphotericin B nanoparticles: antifungal activity, bioavailability and toxicity in rats.

Authors:  Mahasen A Radwan; Bushra T AlQuadeib; Lidija Šiller; Matthew C Wright; Benjamin Horrocks
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

4.  Self-assembled amphotericin B-loaded polyglutamic acid nanoparticles: preparation, characterization and in vitro potential against Candida albicans.

Authors:  Qamar Zia; Aijaz Ahmed Khan; Zubair Swaleha; Mohammad Owais
Journal:  Int J Nanomedicine       Date:  2015-03-05

Review 5.  Polymeric plant-derived excipients in drug delivery.

Authors:  Carien E Beneke; Alvaro M Viljoen; Josias H Hamman
Journal:  Molecules       Date:  2009-07-16       Impact factor: 4.411

6.  Alginate-amphotericin B nanocomplexes covered by nanocrystals from bacterial cellulose: physico-chemical characterization and in vitro toxicity.

Authors:  Victória Soares Soeiro; Ricardo Silva-Carvalho; Daniela Martins; Pier Parpot; Denise Grotto; Marco Vinicius Chaud; Francisco Miguel Portela da Gama; Angela Faustino Jozala
Journal:  Sci Rep       Date:  2021-12-14       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.